v3.26.1
Research and Development Funding Arrangements (Details)
$ in Millions
3 Months Ended 12 Months Ended
Apr. 24, 2026
USD ($)
Apr. 24, 2026
USD ($)
Apr. 25, 2025
USD ($)
agreement
Apr. 26, 2024
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Other operating expense (income), net   $ 221 $ (8) $ 11
Blackstone Arrangement, Specific Diabetes Products | Blackstone        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer $ 0 $ 0 46 $ 60
Funding recognized     324  
Royalty payment term 1   2 years    
Royalty payment term 2   2 years    
Royalty payment term 3   5 years    
Other operating expense (income), net $ 157      
Contract termination fee   $ 216    
Collaborative Arrangement, Revenue Not from Contract with Customer, Statement of Income or Comprehensive Income [Extensible Enumeration] Other operating expense (income), net      
Blackstone Arrangement, Specific Diabetes Products, MiniMed Fit Patch Pump | Blackstone        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Royalty payment   162    
Blackstone Arrangement, Specific Diabetes Products, MiniMed Flex Insulin Pump | Blackstone        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Royalty payment   $ 157    
Blackstone Arrangement, Co-Development Arrangements | Blackstone        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Funding recognized     $ 212  
Number of agreements terminated | agreement     2  
Litigation charges     $ 165